Long-term Clinical Outcomes of Kidney Re-transplantation

Transplant Proc. 2017 Jun;49(5):997-1000. doi: 10.1016/j.transproceed.2017.03.057.

Abstract

Background: Kidney re-transplantation is commonly considered to have a higher immunological risk than first kidney transplantation. Because of the organ shortage and increasing waiting lists, long-term outcomes of kidney re-transplantation are being studied. However, reports of re-transplantation outcomes are not common. We have reported our 30 years of experience with second kidney transplantations.

Methods: Of 1210 kidney transplantations between November 1982 and August 2016 performed in our hospital, 105 were second kidney transplantations (2nd KT). Living donor KT was 44; deceased donor KT was 61.

Results: Patient survival rates at 1, 5, and 10 years were 100%, 97.2%, and 90.7%, and graft survival rates were 97.0%, 94.6%, and 71.5%, respectively. The leading cause of graft failure in the 2nd KT was chronic rejection (60%). In addition, induction immunosuppressant, maintenance immunosuppressant, delayed graft function, and graft survival time at the 1st KT had a significant impact on graft survival time at the 2nd KT.

Conclusions: Reasonable results in both patient survival and graft survival rates were found in the 2nd KT. Careful monitoring of immunologic risk is needed.

MeSH terms

  • Female
  • Graft Rejection
  • Graft Survival*
  • Humans
  • Kidney Transplantation / mortality*
  • Male
  • Middle Aged
  • Reoperation / mortality*
  • Survival Rate